Home > products > phospholipids
> lipids-for-drug-delivery
> surface-reactive-doxorubicin-liposomes-fa
Surface Reactive Doxorubicin Liposomes-FA (PEGylated)
Surface Reactive Doxorubicin Liposomes-FA (PEGylated)
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-C-6764 | 2ml | 765.00 | + Add to cart |
|
R-C-6764 | 5ml | 1710.00 | + Add to cart |
|
|
Product description
Surface Reactive Doxorubicin Liposomes-Folate(PEGylated)represent a promising strategy in cancer therapy.By integrating the design features of liposomes,the benefits of PEGylation,and the targeting capability of folate functionalization,this formulation aims to enhance the effectiveness of doxorubicin while minimizing the unwanted side effects often associated with chemotherapy.Future investigations,including clinical trials,will be essential to validate the therapeutic potential and safety of this targeted drug delivery system in various oncological settings.
Appearance | N/A |
---|---|
Inside Buffer/Outside Buffer | Ammonium Sulfate/Phosphate Buffered Saline |
PH | 7.4 |
Liposome Size | 100nm |
Encapsulated Doxorubicin | 2 mg/ml (3.45 mM) |
Storage | Store at 4 ℃ away from light |
Transportation | 4-25℃temperature for up to 3 weeks |
Stability | 6 months |
Document
Related Product